NL8101987A - De verbinding 4-amino-1-beta-d-ribofuranosyl-1h-imidazo/4.5-c/-pyridine of een farmaceutisch aanvaardbaar zuuradditiezout daarvan; farmaceutisch preparaat. - Google Patents

De verbinding 4-amino-1-beta-d-ribofuranosyl-1h-imidazo/4.5-c/-pyridine of een farmaceutisch aanvaardbaar zuuradditiezout daarvan; farmaceutisch preparaat. Download PDF

Info

Publication number
NL8101987A
NL8101987A NL8101987A NL8101987A NL8101987A NL 8101987 A NL8101987 A NL 8101987A NL 8101987 A NL8101987 A NL 8101987A NL 8101987 A NL8101987 A NL 8101987A NL 8101987 A NL8101987 A NL 8101987A
Authority
NL
Netherlands
Prior art keywords
adenosine
deaza
pharmaceutically acceptable
ribofuranosyl
imidazo
Prior art date
Application number
NL8101987A
Other languages
English (en)
Dutch (nl)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NL8101987A publication Critical patent/NL8101987A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052Imidazole radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8101987A 1980-04-23 1981-04-22 De verbinding 4-amino-1-beta-d-ribofuranosyl-1h-imidazo/4.5-c/-pyridine of een farmaceutisch aanvaardbaar zuuradditiezout daarvan; farmaceutisch preparaat. NL8101987A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8013411A GB2074858B (en) 1980-04-23 1980-04-23 Compositions containing 3-deazaaden-osine
GB8013411 1980-04-23

Publications (1)

Publication Number Publication Date
NL8101987A true NL8101987A (nl) 1981-11-16

Family

ID=10512973

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8101987A NL8101987A (nl) 1980-04-23 1981-04-22 De verbinding 4-amino-1-beta-d-ribofuranosyl-1h-imidazo/4.5-c/-pyridine of een farmaceutisch aanvaardbaar zuuradditiezout daarvan; farmaceutisch preparaat.

Country Status (15)

Country Link
EP (1) EP0038567B1 (ja)
JP (1) JPS56166118A (ja)
AU (1) AU553680B2 (ja)
BE (1) BE888525A (ja)
CA (1) CA1172168A (ja)
CH (1) CH654316A5 (ja)
DE (2) DE3176462D1 (ja)
DK (1) DK179781A (ja)
GB (1) GB2074858B (ja)
IE (2) IE51738B1 (ja)
IL (1) IL62696A (ja)
IT (1) IT1170910B (ja)
NL (1) NL8101987A (ja)
NZ (1) NZ196883A (ja)
ZA (1) ZA812640B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU596637B2 (en) * 1986-08-06 1990-05-10 Sumitomo Chemical Company, Limited Mulching film for repelling insect pests
US4918060A (en) * 1987-09-04 1990-04-17 The Johns Hopkins University Method of treating myasthenia gravis and related diseases
US5137876A (en) * 1990-10-12 1992-08-11 Merck & Co., Inc. Nucleoside antiviral and anti-inflammatory compounds and compositions and methods for using same
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US6693088B1 (en) 1998-09-03 2004-02-17 Kerckhoff-Klinik Gesellschaft MIT Beschränkter Haftung 3-deazaadenosine prevents atherosclerosis and graft vasculopathy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148888A (en) * 1978-03-13 1979-04-10 The United States Of America As Represented By The Department Of Health, Education And Welfare 3-Deazaadenosine as an inhibitor of adenosylhomocysteine hydrolase with antiviral activity
EP0010668B1 (en) * 1978-10-13 1986-01-22 The Wellcome Foundation Limited 3-deazaadenosine and pharmaceutical compositions containing it

Also Published As

Publication number Publication date
IE811594L (en) 1981-10-23
CA1172168A (en) 1984-08-07
DK179781A (da) 1981-10-24
DE3116029A1 (de) 1982-03-18
JPH0428686B2 (ja) 1992-05-15
IT1170910B (it) 1987-06-03
CH654316A5 (de) 1986-02-14
JPS56166118A (en) 1981-12-21
IE810891L (en) 1981-10-23
AU6971081A (en) 1981-10-29
NZ196883A (en) 1984-07-31
DE3116029C2 (ja) 1991-01-17
IE51737B1 (en) 1987-03-18
IL62696A0 (en) 1981-06-29
EP0038567A1 (en) 1981-10-28
GB2074858A (en) 1981-11-11
IL62696A (en) 1984-03-30
DE3176462D1 (en) 1987-10-29
AU553680B2 (en) 1986-07-24
ZA812640B (en) 1982-12-29
GB2074858B (en) 1985-03-20
EP0038567B1 (en) 1987-09-23
IE51738B1 (en) 1987-03-18
IT8148327A0 (it) 1981-04-22
BE888525A (fr) 1981-10-22

Similar Documents

Publication Publication Date Title
US5401777A (en) Use of preparations of curcuma plants
US6054486A (en) Use of 9-Deoxy-2',9-α-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-dihydro-prostaglandin f1 to treat peripheral vascular disease
EP0098743B1 (en) Phenyl alpha-acyloxyacetamide derivates and their therapeutic use
US4322411A (en) Anti-inflammatory nucleosides
US5260335A (en) Pharmaceutical preparations for the treatment of inflammatory diseases
US4720503A (en) N-substituted fused-heterocyclic carboxamide derivatives as dual cyclooxygenase and lipoxygenase inhibitors
US5190947A (en) Codeine salt of a substituted carboxylic acid, its use and pharmaceutical compositions thereof
EP1970372B1 (en) Salts of 9-oxoacridine-10-acetic acid with 1-alkylamno-1-desoxy-polyols
NL8101987A (nl) De verbinding 4-amino-1-beta-d-ribofuranosyl-1h-imidazo/4.5-c/-pyridine of een farmaceutisch aanvaardbaar zuuradditiezout daarvan; farmaceutisch preparaat.
EP4262979A1 (en) Cannabinoid derivative as a pharmaceutically active compound and method of preparation thereof
US4007268A (en) Process for alleviating proliferative skin diseases
US5276044A (en) Leukotriene receptor antagonist and antihistamine complex pharmaceutical compositions
EP0543855A1 (en) Use of aryl hydroxyurea compounds for the treatment of atherosclerosis
US4814353A (en) Therapeutic and prophylactic agent for gastritis
JPH03294230A (ja) 子宮内膜症治療剤
US3143469A (en) Anti-cholesterol nicotinic acid nu-oxide
JPS60158149A (ja) 炎症抑制作用を有する1,4‐ナフトキノン誘導体
CZ20021433A3 (cs) Proléčivo na bázi 6-methoxy-2-naftyloctové kyseliny
JPS6245525A (ja) 脂質低下剤
US4391809A (en) Methods for treating psoriasis
US5461072A (en) Use of aryl hydroxyurea compounds for the treatment of atherosclerosis
EP0121856A2 (de) Verwendung von Pyrazolonderivaten bei der Bekämpfung des Wachstums von Tumorzellen und der Metastasenbildung, Arzneimittel hierfür und Verfahren zu deren Herstellung
JP3990728B2 (ja) N−[4−オキソ−2−(1h−テトラゾール−5−イル)−4h−1−ベンゾピラン−8−イル]−4−(4−フェニルブトキシ)ベンズアミドの塩
US3851064A (en) Diphenylsulfides as hypolipidemics
SK5512002A3 (en) Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of disease states as a result of ischaemic conditions

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed